Post Job Free

Resume

Sign in

Medical Health

Location:
South Portland, ME
Posted:
February 04, 2014

Contact this candidate

Resume:

January ****

Kevin L. Wallace, MD, FACMT

Contact Information

Forensic MedTox, LLC Website: www.forensicmedtox.com

P.O. Box 50982 Email: acchyz@r.postjobfree.com

Sarasota, FL 34232-0308 Tel: 207-***-****

Summary Profile

Dr. Wallace is Founder and Director of Forensic MedTox, LLC, as established in June of 2013 and posted

on the website cited above. For more than 15 years, he has provided forensic medical toxicology

consultant and expert witness service, based on his education, experience, training, board certification,

and professional experience, and has held clinical and academic positions in numerous geographic and

professional settings.

Employment

2013-present Forensic MedTox, LLC South Portland, Maine

Founder/Director/Forensic Expert Witness/Consultant

2004-present Veritox, Inc. Redmond, Washington

Part-time Director of Medical Toxicology

2010-2012 University of New England College of Pharmacy Portland, Maine

Full-time Faculty Member, Department of Pharmacy Practice

1997-2010 Banner Good Samaritan Medical Center Phoenix, Arizona

Phoenix Children’s Hospital (1997-2008)

Attending Physician, Department of Medical Toxicology;

Director, Occupational & Environmental Toxicology Services;

Associate Director, Banner Poison Center

2008-2009 University of Virginia Health System Charlottesville, Virginia

Attending Physician, Department of Emergency Medicine,

Division of Medical Toxicology

2003-2008 Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire

Attending Physician, Department of Medicine: Division of Clinical

Pharmacology and Toxicology; Division of Occupational and

Environmental Medicine

2004-2006 Center for Environmental Health Sciences at Dartmouth Hanover, New Hampshire

Associate Director

2003-2004 Maricopa Medical Center Phoenix, Arizona

Courtesy Staff Physician, Department of Emergency Medicine

2002-2004 New Hampshire Poison Information Center Lebanon, New Hampshire

Medical Director

Kevin L. Wallace, MD, FACMT

1999-2004 City of Phoenix Fire Department Phoenix, Arizona

Medical Review Officer

1993-1995 Maine Poison Center Portland, Maine

Medical Director

1988-1995 Maine Medical Center Portland, Maine

Attending Physician, Emergency Department

1987-1988 Crawford W. Long Hospital Atlanta, Georgia

Attending Physician, Emergency Department

1984-1985 Southside Community Hospital Farmville, Virginia

Staff Physician, Emergency Department

1977-1979 Harvard Medical School/Robert B. Brigham Hospital Boston, Massachusetts

Research Assistant

Professional Licensure/Board Certification

Florida Department of Health – Medical Doctor Expert Witness

2013-present

1999-present American Board of Emergency Medicine - Medical Toxicology

1988-present Maine Board of Licensure in Medicine

1984-present Commonwealth of Virginia Board of Medicine

1995-2010 Arizona Medical Board

1998-2009 Medical Review Officer Certification Council (MROCC)

2002-2008 New Hampshire Board of Medicine

ABEM – Emergency Medicine

1988-2007

1985-1988 State of Georgia Board of Medicine

Education/Training

2011 University of New England Portland, Maine

Graduate studies: Environmental Health Science

2007-2008 University of Southern Maine Portland, Maine

Graduate studies: Health Care Management; Epidemiological Research

1999 Arizona State University Tempe, Arizona

Graduate studies: Clinical Epidemiology & Biostatistics

2

Kevin L. Wallace, MD, FACMT

1995-1997 Good Samaritan Regional Medical Center Phoenix, Arizona

Medical Toxicology Fellowship

1985-1987 Emory University/Grady Memorial Hospital Atlanta, Georgia

Emergency Medicine Residency

1983-1984 University of Virginia/Roanoke Memorial Hospitals Roanoke, Virginia

Medical Internship

1979-1983 University of Virginia School of Medicine Charlottesville, Virginia

Medical Degree

1972-1976 Amherst College Amherst, Massachusetts

Bachelor of Arts

Academic Appointments

2010-2012 University of New England College of Pharmacy Portland, Maine

Associate Professor, Department of Pharmacy Practice

1999-2010 University of Arizona College of Medicine Tucson, Arizona

Clinical Associate Professor, Department of Emergency Medicine,

Division of Medical Toxicology

2008-2009 University of Virginia School of Medicine Charlottesville, Virginia

Adjunct Clinical Faculty, Department of Emergency Medicine,

Division of Medical Toxicology

2006-2008 University of Massachusetts Medical School Worcester, Massachusetts

Adjunct Clinical Faculty, Department of Emergency Medicine,

Division of Medical Toxicology

2004-2008 Dartmouth Medical School Hanover, New Hampshire

Clinical Adjunct Associate Professor of Medicine,

Division of Pharmacology and Toxicology

1989-1995 University of Vermont School of Medicine Burlington, Vermont

Clinical Assistant Professor, Department of Surgery

1987-1988 Emory University School of Medicine Atlanta, Georgia

Clinical Assistant Professor, Department of Preventive Medicine,

Division of Emergency Medicine

Professional Association Membership

1995-present American College of Medical Toxicology

1993-2012 American Academy of Clinical Toxicology

3

Kevin L. Wallace, MD, FACMT

2005-2008 American College of Occupational and Environmental Medicine

1997-2008 Association of Occupational and Environmental Clinics

1985-2002 American College of Emergency Physicians

1991-1995 Society of Academic Emergency Medicine

1988-1992 National Association of EMS Physicians

Professional Honors and Awards

“Highly Commended”, British Medical Association Book Competition

2005

2002 Fellow, American College of Medical Toxicology

2000 Micromedex Best Scientific Abstract, North American Congress of Clinical

Toxicology

1999 Fellow, American College of Emergency Physicians

1987 Chief Resident in Emergency Medicine, Emory University

Professional and Community Outreach

Committee/Work Group Activities

2011-present Member, ACMT Education Committee

2011-present Member, ACMT Medication Management Section

2012-2013 Board Member, Maine Division of New England Rural Health Round Table

2012-2013 Board Member, H.O.P.E. Group

2009-2013 Member, State of Maine Academic Detailing Advisory Committee

2011-2012 Member, Occupational Medicine Tox Task Forum

2009 Member, Inhalation Toxicology Advisory Group, Virginia Dept. of Environ. Quality

2007-2008 Member, ACMT Liaison Committee

2006-2009 Reviewer, North American Congress of Clinical Toxicology Abstract Committee

2006-2010 Member, ACMT Practice Committee

2007 Reviewer, ATSDR/ACMT Chemical Agents of Opportunity Course

4

Kevin L. Wallace, MD, FACMT

2006 Reviewer, Immunotoxicology, Toxicology Principles for the Industrial Hygienist

(AIHA)

2006 Reviewer, NIH/NINDS CounterACT grant program

2006 Reviewer, ACEP Clinical Policies Subcommittee

2002-2005 Member, State of New Hampshire Public Health Laboratories, Biomonitoring Council

1999-2001 Member, Pharmacy & Therapeutics Committee, Banner Good Samaritan Medical

Center

1997-1999 Member, ToxMedic Committee, Bureau of EMS, Arizona Department of Health

Services

1993-1995 Member, Medical Advisory Committee, State of Maine Board of Pesticides Control

1988-1992 Member, Medical Control Board, Southern Maine EMS

Publications

Textbooks

Brent J, Wallace KL, Burkhart KK, Phillips SD, Donovan JW, eds. Critical Care Toxicology – Diagnosis

and Management of the Critically Poisoned Patient. Philadelphia, PA:Elsevier Mosby. 2005.

Book Chapters

Wallace KL, Kunkel DB. Carbon disulfide. In: Sullivan JB, Krieger GR, eds. Clinical Environmental

Health and Toxic Exposures, 2nd edition. Philadelphia, PA: Lippincott, Williams & Wilkins.

2001:1206-1211.

Wallace KL: Carbon Monoxide. In Ling LJ, Clark RF, Erickson, TB, Trestrail, JH (eds): Toxicology

Secrets. Philadelphia, PA:Hanley & Belfus. 2001:215-220.

Wallace KL, Morkunas A. Geriatric poisoning. In: Brent J, Wallace KL, Burkhart KK, Phillips SD,

Donovan JW, eds. Critical Care Toxicology – Diagnosis and Management of the Critically Poisoned

Patient. Philadelphia, PA: Elsevier Mosby. 2005:141-147.

Wallace KL. Toxin-induced seizures. In: Brent J, Wallace KL, Burkhart KK, Phillips SD, Donovan JW,

eds. Critical Care Toxicology – Diagnosis and Management of the Critically Poisoned Patient.

Philadelphia, PA: Elsevier Mosby. 2005:225-239.

Tomassoni AJ, Wallace KL. Imidazoline, guanidine, and oxazoline antihypertensives and decongestants.

In: Brent J, Wallace KL, Burkhart KK, Phillips SD, Donovan JW, eds. Critical Care Toxicology –

Diagnosis and Management of the Critically Poisoned Patient. Philadelphia, PA: Elsevier Mosby.

2005:441-447.

5

Kevin L. Wallace, MD, FACMT

Wallace KL, Brooks DE. Anxiolytic/sedative-hypnotics. In: Brent J, Wallace KL, Burkhart KK, Phillips

SD, Donovan JW, eds. Critical Care Toxicology – Diagnosis and Management of the Critically Poisoned

Patient. Philadelphia, PA:Elsevier Mosby. 2005:533-546.

Katz KD, Wallace KL. Anti-Parkinson’s medications. In: Brent J, Wallace KL, Burkhart KK, Phillips

SD, Donovan JW, eds. Critical Care Toxicology – Diagnosis and Management of the Critically Poisoned

Patient. Philadelphia, PA:Elsevier Mosby. 2005:583-595.

Munday S, Wallace KL. Flumazenil. In: Brent J, Wallace KL, Burkhart KK, Phillips SD, Donovan JW,

eds. Critical Care Toxicology – Diagnosis and Management of the Critically Poisoned Patient.

Philadelphia, PA:Elsevier Mosby. 2005:1493-1497.

Wallace KL. Pentachlorophenol. In: Hoffman HE, Palmer RB, Phillips S, eds. Clinical Practice of

Biological Monitoring. Beverly Farms, MA:OEM Press. 2012:166-169.

Journal Articles

Glass D, Litvin D, Wallace KL, et al: Early-onset particular JRA associated with HLA-DRw5, iritis, and

ANA. J Clin Invest 1980; 66:426-429.

Wallace KL, Slovis CM: Hepatic vein bullet embolus as a complication of left thoracic gunshot injury.

Ann Emerg Med 1987; 16(1):102-104.

Wallace KL, Slovis CM: Altered mental status. Case Studies in Emergency Medicine 1987; 3(6):9-11.

Wallace KL: Prehospital quality assurance: focus on product evaluation. J Maine EMS 1990; 1(1):14-15.

Wallace KL: New airway management devices. J Maine EMS 1990; 1(2):14-19.

Wallace KL: Prehospital esophageal airways: another role for endtidal CO2 detection? J Maine EMS

1991; 2(2):17-18.

Clark D, Zeiger M, Wallace KL, et al: Blunt aortic trauma: signs of high risk. J Trauma 1990;

30(6):701-705.

Higgins GL, Campbell B, Wallace KL, Talbot S: Pediatric poisoning from over-the-counter imidazoline-

containing products. Ann Emerg Med 1993; 20(6):655-658.

Higgins GL, Lambrew C, Hunt E, Wallace KL, et al: Expediting the early hospital care of the adult

patient with nontraumatic chest pain: impact of a modified ED triage protocol. Am J Emerg Med 1993;

11(6):576-582.

Wallace KL: Antibiotic-induced convulsions. Crit Care Clin N Am 1997; 13(4): 741-761.

Wallace KL, Morkunas AR: Commonly abused prescription sedative hypnotic drugs. Topics Emerg

Med 1997; 19(4):26-37.

Wallace KL, Curry SC, LoVecchio F, Raschke RA: Effect of magnesium hydroxide on iron absorption

following simulated mild iron overdose in human subjects. Acad Emerg Med 1998; 5(10):961-965.

6

Kevin L. Wallace, MD, FACMT

Suchard JR, Wallace KL, Gerkin RD: Acute cyanide toxicity caused by apricot kernel ingestion. Ann

Emerg Med 1998; 32(6):742-4.

Wallace KL, Suchard J, Curry SC, Reagan C: Diagnostic Use of Physicians' Detection of Urine

Fluorescence in a Simulated Ingestion of Sodium Fluorescein-Containing Antifreeze. Ann Emerg Med

2001; 38(1):49-54.

LoVecchio FL, Curry SC, Graeme KA, Wallace KL, Suchard J: Intravenous pyridoxine-induced

metabolic acidosis. Ann Emerg Med 2001; 38(1):62-64.

Brent J, McMartin K, Phillips S, Burkhart KK, Donovan JW, Wells M, Kulig K, Bogdan G, Dart R,

Heard K, Kokan L, Akhtar J, Ahsan N, Zimmerman H, Curry S, Wallace K, et al. Fomepizole for the

treatment of ethylene glycol poisoning. N Eng J Med 1999;340;832-8.

Wallace KL, Curry SC: Post-collection rise in methemoglobin level in frozen blood specimens. J

Toxicol Clin Toxicol 2002; 40(1):91-94.

Ruha AM, Curry SC, Beuhler M, Katz K, Brooks DB, Graeme KA, Wallace KL, et al. Initial

postmarketing experience with Crotalidae polyvalent immune Fab for treatment of rattlesnake

envenomation. Ann Emerg Med 2002; 39(6):609-615.

Brooks DE, Wallace KL. Acute propylene glycol ingestion. J Toxicol Clin Toxicol 2002;40(4):513-516.

LoVecchio F, Cannon RD, Algier J, Ruha A, Curry SC, Wallace KL, Graeme KA. Bee swarmings in

children. Am J Emerg Med 2007;25:931-933.

Charlton N, Wallace KL. American College of Medical Toxicology Position Statement on Post-Chelator

Challenge Urinary Metal Testing. J Med Toxicol 2010;6:74-75.

McCall KL, Tu C, Lacroix M, Holt C, Wallace KL, Balk J. Controlled substance prescribing trends and

physician and pharmacy utilization patterns: epidemiological analysis of the Maine Prescription

Monitoring Program from 2006 to 2010. Journal of Substance Use 2012 (doi: 10.3109/14659891.2012.

685794)

Murphy CM. (Leikin J, Brent J, Wallace K, Beuhler M, Raymond L). Fear not the IME. J Med Toxicol

2012;8:3-4.

Letters to the Editor

Suchard J, Wallace KL, et al: Cutaneous nodular reaction to oral mercury. J Am Acad Dermatol 1998;

38(5:1):784-785.

Wallace KL, Graeme KA, Morkunas A, Curry SC: Zolpidem binds to w, not m, receptors. J Toxicol

Clin Toxicol 1998; 36(1&2):143-144.

Wallace KL, Curry SC, LoVecchio F, Raschke RA: Effect of magnesium hydroxide on iron absorption

after ferrous sulfate. Ann Emerg Med 1999; 34(5):685-686.

7

Kevin L. Wallace, MD, FACMT

Wallace KL, Kunkel DB: Legal hemp products and urine cannabinoid testing. J Toxicol Clin Toxicol

1999; 37(7):897-898.

Wallace KL, Suchard J: Food pollution. Otolaryngol Head Neck Surg 2000; 122(3):466-467.

Ruha A, Wallace KL, Tanen DA, Patel P: Dilute diquat death. Am J Emerg Med 2001; 19(6):527-528.

LoVecchio F, Pizon AF, Wallace KL, Kunkel DB. Myokymia following snake envenomation in Arizona.

Wilderness Environ Med 2005; 16:116-117

Charlton NP, Lawrence DT, Wallace KL. Falsely elevated salicylate levels. J Med Toxicol 2008;

4(4):310-311.

Abstracts

Wallace KL, Slovis CM: Case presentation: the patient with altered mental status. Abstract. South Med

J 1986; 79:9 (Suppl. #2):15

Naylor JK, Riker RR, Wallace KL: Critical care Toxicology: ICU vs non-ICU admission, substance type,

and therapeutic interventions. Am J Respir Crit Care Med 1995; 151: A491.

Wallace KL, Gerkin R, Mitchell R: Acute cyanide toxicity due to apricot kernel ingestion. J Toxicol Clin

Toxicol 1996; 34(5):599.

Wallace KL, LoVecchio F, Kunkel DB, Carlton MW: Myokymia following snake envenomation in

Arizona. J Toxicol Clin Toxicol 1997; 35(5):531-532.

Wallace KL, Curry SC, Graeme K: Effectiveness of flumazenil in the reversal of baclofen-induced CNS

depression in rats. J Toxicol Clin Toxicol 1997; 35(5):548.

Wallace KL, Curry SC, LoVecchio FL, Raschke RA: Effect of magnesium oxide on iron absorption

following simulated iron overdose in human beings: a randomized controlled trial. J Toxicol Clin

Toxicol 1997; 35(5):563-564.

Graeme KA, Wallace KL, Curry SC, Tanen DA, Higgins TJ: Hydrogen sulfide-induced changes in coin

appearance. J Toxicol Clin Toxicol 1998; 36(5):469.

LoVecchio F, Curry SC, Wallace KL, Graeme KA, Suchard JR: Pyridoxine hydrochloride infusion effect

on acid-base status. J Toxicol Clin Toxicol 1998; 36(5): 428.

Wallace KL, Suchard J, Curry SC, Reagan C: Accuracy and reliability of urine fluorescence by Wood's

lamp examination for antifreeze ingestion. J Toxicol ClinToxicol 1999; 37(5):669.

Wallace KL, Curry SC, Brooks D: Post-collection rise in methemoglobin level in frozen blood. J

Toxicol Clin Toxicol 2000; 38(5):522.

Wallace KL, Gerkin R, Gatewood P: Demonstration of clobenzorex exposure as an explanation for

GC/MS-confirmed positive urine tests specific for amphetamine. J Toxicol Clin Toxicol 2000;

38(5):540-541.

8

Kevin L. Wallace, MD, FACMT

Brooks DE, Wallace KL, Katz K: Acute propylene glycol ingestion. J Toxicol Clin Toxicol 2001;

39(5):482.

Ruha AM, Beuhler M, Brooks D, Wallace KL et al: CroFab for treatment of rattlesnake envenomation. J

Toxicol Clin Toxicol 2001; 39(5):546.

Oehme FW, Coppock RW, Wallace KL, Peterson ME, et al. Toxicology of naturally occurring toxins.

Toxicol Sci 2002; 66(1-S):2.

Brooks D, Wallace KL, Wax P, Watts D, Holubek W: Misleading liver needle biopsy in transplant

evaluation for acetaminophen-induced fulminant liver failure. J Toxicol Clin Toxicol 2002; 40(5):606.

LoVecchio F, Klemens J, Curry SC, Wallace KL. Validation of a metformin poison center Protocol: a

48-month experience in toddlers. J Toxicol Clin Toxicol 2003; 41(5):683.

Beuhler MC, Wallace KL. Benign outcome with toxic serum iron levels following IV iron dextran

overdose in three patients. J Toxicol Clin Toxicol 2003; 41(5):738-739.

LoVecchio F, Watts D, Curry SC, Wallace KL. Acute renal failure, neuropathy, and myopathy after

ingestion of dipropylene glycol-containing Fantasiaä fog solution. J Toxicol Clin Toxicol 2003;

41(5):647.

LoVecchio F, Pizon AF, Wallace KL, Kunkel DB. Myokymia following snake envenomation in Arizona.

Wilderness Environ Med 2005; 16:116-117.

Cannon R, Wallace K. Rapid clinical improvement after carnitine administration in valproate-induced

hyperammonemic encephalopathy (VHE). Clin Toxicol 2007;45(6):625.

Riley BD, Quan D, Wallace KL. Early MRI findings do not appear predictive of outcome in severe

ethylene glycol-induced brain injury. Clin Toxicol 2007;45(6):628.

Gresham C, Wallace KL. Challenges in detection and confirmation of modafinil use. Clin Toxicol

2008;46(7):642.

Other Publications

Platinum. In: The Third National Report on Human Exposure to Environmental Chemicals. National

Center for environmental Health, DHHS, Washington, D.C. 2005:56-58.

Thallium. In: The Third National Report on Human Exposure to Environmental Chemicals. National

Center for environmental Health, DHHS, Washington, D.C. 2005:59-61.

Wallace KL. Recognizing and reducing risks of narcotic analgesic harm. Blue Ridge Poison Center Tox

Talks. November 2008. Available@: http://www.healthsystem.virginia.edu/internet/medtox/education/

toxtalks/Nov08NarcoticAnalgesics.pdf.

Wallace KL. Health effects of indoor exposure to mold and mold toxins. Blue Ridge Poison Center Tox

Talks. May 2009. Available @: http://www.healthsystem.virginia.edu/internet/medtox /education/

toxtalks/May09-Mold.pdf.

9

Kevin L. Wallace, MD, FACMT

Presentations

Community Educational Presentations

Environmental Illness/MCS. Jones, Skelton & Hochuli Insurance Law Seminar, Phoenix, AZ (May 1997)

Legal Aspects of Blood Alcohol. Industrial Commission of Arizona Annual Seminar, Mesa, AZ (August

1997)

Hydrofluoric Acid. Environmental Health and Safety Summit Conference. ON Semiconductor, Phoenix,

AZ (October 2000)

Toxic Gases of the Semiconductor Industry. Environmental Health and Safety Summit Conference. ON

Semiconductor, Phoenix, AZ (October 2000)

Biological Monitoring of Mercury Exposure. State of New Hampshire Office of Community and Public

Health, Bureau of Health Risk Assessment, Concord, NH (October 2001)

Health Effects of Indoor Mold Contamination. State of Arizona Risk Management, Phoenix, AZ

(February 2002)

Health Effects of Indoor Mold Contamination. 2002 Annual Update of Arizona Law, Phoenix, AZ (May

2002)

Chemical Irritant Inhalational Injury. Industrial Commission of Arizona Annual Seminar Phoenix, AZ

(August 2002)

Mold Mania. Certified Hazardous Materials Managers Meeting. Phoenix, AZ (March 2004)

Acute Chemical Irritant-induced Respiratory Tract Injury. Rehabilitation Insurance Nurses Group,

Monthly Meeting. Phoenix, AZ (January 2006)

Health Effects of Indoor Mold Exposure. Northern New England Defense Counsel Association.

Woodstock, VT (March 2006)

Acute Airborne Chemical Irritant Injury. Workers Compensation Claims Division. St. Paul Travelers.

Phoenix, AZ (June 2006)

Health Effects of Indoor Mold Exposure. True North Health Center. Falmouth, ME (June 2006)

Medical Toxicology: Background, Scope of Practice, and Guiding Principles. American Association of

Legal Nurse Consultants. Phoenix, AZ (November 2006)

Approach to Workplace Toxic Exposure Claim. Arizona Workers Compensation Claims Association

Seminar. Phoenix, AZ (February 2007)

Environmental Risk Factors for Cancer. 2007 Living with Cancer Conference. American Cancer

Society. Augusta, ME (May 2007)

10

Kevin L. Wallace, MD, FACMT

Perilous Polypharmacy. Medical Staff CME Meeting. Rockingham Memorial Hospital, Harrisonburg,

VA (June 2009)

Partnering in Medication Safety. Presentation to the Elderly. Cape Elizabeth Community Services, Cape

Elizabeth, ME (September 2009)

Partnering in Medication Safety. Presentation to the Elderly. Sunnyside Village Retirement Community,

Sarasota, FL (October 2009)

OccTox Exposure Claims, Arizona Workers Comp Claims Adjustors Association, Monthly Dinner

Meeting Presentation, Phoenix, AZ (November 2009)

Partnering in Medication Safety, Presentation to Mental Health Support Group, Family Involvement

Center, Phoenix, AZ (November 2009)

Perilous Polypharmacy - Partnering in Medication Safety. St. George's Episcopal Church, Sanford, ME

(October 2012)

Medical Professional Presentations

Pediatric Pain Management. Emergency Medicine Update, Colby College, Waterville, ME (July 1988)

Diabetic Ketoacidosis. Annual Conference on Acute Medical Problems for the Primary Care Physician

Assistants, Portland, ME (September 1989)

EMS Controversies. Emergency Medicine Winter Symposium, Sugarloaf, Waterville, ME (March 1991)

EMS Controversies. Emergency Medicine Update, Colby College, Waterville, ME (July 1991)

Carbon Monoxide Poisoning. Annual Conference on Acute Medical Problems for the Primary Care

Physician Assistants, Portland, ME (September 1991)

Lightning Injuries. Emergency Medicine Update, Colby College, Waterville, ME (July 1992)

Electrical and Lightning Injuries. Annual Conference on Acute Medical Problems for the Primary Care

Physician Assistants, Portland, ME (September 1992)

Electrical and Lightning Injuries. Grand Rounds, Dept. of Emergency Medicine, Maine Medical Center,

Portland, ME (September 1992)

Drugs of Abuse. Emergency Medicine Winter Symposium, Sugarloaf, ME ( February 1993)

Street Drugs. Emergency Medicine Update, Colby College, Waterville, ME (August 1993)

Prescription Drug Seeking. Annual Conference on Acute Medical Problems for the Primary Care

Physician Assistants, Portland, ME (September 1993)

Living with Prozac Overdose. Medical Update Conference, Dept. of Psychiatry, Maine Medical Center,

Portland, ME (December 1993)

11

Kevin L. Wallace, MD, FACMT

Street Drugs. Annual Conference on Acute Medical Problems for the Primary Care Physician Assistants,

Portland, ME (October 1994)

Opioid Abuse/Dependence. Medical Update Conference, Dept. of Psychiatry, Maine Medical Center,

Portland, ME (November 1994)

Street Drug Management Controversies. Emergency Medicine Winter Symposium, Sugarloaf,

Waterville, ME (March, 1995)

Clinical Pharmacology & Toxicology Review. Mayo Clinic Internal Medicine Board Review, Scottsdale,

AZ (August 1997)

Controversies in Pediatric Toxicology. Pediatric Grand Rounds. St. Joseph’s Children’s Health Center,

Phoenix, AZ (December 1997)

Common Southwestern Arthropod Envenomations. Continuing Education Series. Huhukam Memorial

Hospital, Gila River Healthcare, Sacaton, AZ (November 1998)

Rattlesnake Envenomation. Continuing Education Series. Huhukam Memorial Hospital, Sacaton, AZ

(March 1999)

Clinical Pharmacology and Toxicology Review. Mayo Clinic Internal Medicine Board Review.

Scottsdale, AZ (August 2000)

The Clinical Toxicology of Neurotransmitters - Nicotinic Neurotransmission (coordinator/moderator).

AACT Symposium. North American Congress of Clinical Toxicology, Tucson, AZ (September 2000)

Mercury Vapor Exposure. Division of Laboratory Sciences, National Center for Environmental Health,

Center for Disease Control, Atlanta, GA (December 2000)

Hydrofluoric Acid Exposure. Dartmouth Hitchcock Medical Center/New Hampshire Poison Information

Center. Lebanon, NH (May 2001)

Rattlesnakes and Gila Monsters: Introduction to Clinical Envenomation. Society of Toxicology 41st

Annual Meeting, Nashville, TN (March 2002)

Sick Building Syndrome/Toxic Mold Menace. Banner Occupational Health Services, Phoenix, AZ (June

2002)

Phantom Risks: How Can We Distinguish Health Scares From True Hazards? New England Regional

Toxicology Conference, Sturbridge, MA (September 2002)

Antihistamines. Department of Pediatrics, Phoenix Children’s Hospital. Phoenix, AZ (March 2003)

Acute Airborne Chemical Irritant Injury. New England Regional Toxicology Conference. Storrs, CT

(September 2003)

Acute Alkyl Mercury Poisoning. New England Regional Toxicology Conference. Storrs, CT (Sept ember

2003)

12

Kevin L. Wallace, MD, FACMT

Chemical Terrorism: Unconventional Use of Conventional Chemicals. Medicine Grand Rounds.

Dartmouth-Hitchcock Medical Center, Lebanon, NH (February 2004)

Fungal Exposure & Health: Toxic versus Allergic Effects. Allergic Dilemmas in Primary Practice.

Hackensack University Medical Center. Hackensack, NJ (April 2004)

Environmental Emergencies: Chemical Terrorism. Grand Rounds. Department of Emergency Medicine,

Maine Medical Center, Portland, ME (April 2005)

Mold Mania. New Hampshire Association of Occupational Nurses Meeting. Manchester, NH (October

2005).

Non-Conventional Potential Agents of Attack. Chemical Agents of Opportunity: TICS and TIMS.

Maine Medical Center, Portland, ME (December 2005)

The Numbing Diversity of Toxic Peripheral Neuropathy. American College of Medical Toxicology

Spring Course. Phoenix, AZ (March 2006)

Terrorism by Fear and Uncertainty. Chemical Agents of Opportunity: TICS and TIMS. Dartmouth-

Hitchcock Medical Center, Lebanon, NH (April 2006)

Assessing and Addressing Hazards and Vulnerabilities. Chemical Agents of Opportunity: TICS and

TIMS. Rhode Island Hospital, Providence, NH (May 2006)

Toxic Peripheral Neuropathy. Harvard Medical Toxicology Fellowship, Children’s Hospital Boston.

Boston, MA (January 2007)

Toxicology of Methadone and Other Opioids. Grand Rounds. Department of Emergency Medicine,

Maine Medical Center, Portland, ME (February 2007)

Forensic Alcohol Test Interpretation. Harvard Medical Toxicology Fellowship, Children’s Hospital

Boston. Boston, MA (April 2007)

Salicylate Poisoning. Grand Rounds. Department of Emergency Medicine, Maine Medical Center,

Portland, ME (August 2007)

Post-Incident Medical Surveillance. Harvard Medical Toxicology Fellowship, Children’s Hospita l

Boston. Boston, MA (August 2007)

Medical Toxicology in the Workplace. Noon Conference. Department of Physical Medicine &

Rehabilitation, University of Virginia Health System. Charlottesville, VA (January 2009)

Toxicological Detection of Substance Abuse in the Emergency Care Setting. Second International

Addiction Medicine Symposium. Universidad de Ciencias Medicas, San Jose, Costa Rica (March 2009)

Nanotoxicology Symposium. Coordinator/Speaker (“Clinical Perspective”). University of Virginia

Division of Medical Toxicology. Charlottesville, VA (May 2009)

13

Kevin L. Wallace, MD, FACMT

Perilous Polypharmacy. Interprofessional Educational Seminar. University of New England College of

Pharmacy. Portland, ME (October 2009)

Perilous Polypharmacy II. University of New England College of Pharmacy. Portland, ME (November

2009)

Perilous Polypharmacy. Harvard Medical Toxicology Fellowship, Children’s Hospital Boston. Boston,

MA (November 2009)

Perilous Polypharmacy - Partnering in Medication Safety. 99th Annual Convention. Maine Osteopathic

Association. Rockport, ME (June 2010)

Polypharmacy. Patient Safety Academy. University of Southern Maine, Portland, ME (August 2010)

Perilous Polypharmacy- Partnering in Medication Safety. 2010 International Symposium on Safe

Medicine. Portland, ME (October 2010)

Perilous Polypharmacy. 5th Annual Psychiatry Update. Maine Association of Psychiatric Physicians.

Portland, ME (April 2011)

Perilous Polypharmacy – Partnering in Medication Safety. CE & SNOW 2012. Maine Society of Health-

System Pharmacists Annual Conference. Sunday River Resort. Bethel, ME (January 2012)

Perilous Polypharmacy - Partnering in Medication Safety. 22nd Annual Maine Geriatrics Conference. Bar

Harbor, ME (June 2012)

Scholarly Platform Presentations

Wallace KL, Curry SC, LoVecchio FL, Raschke RA: Effect of magnesium oxide on iron absorption

following simulated iron overdose in human beings: a randomized controlled trial. North American

Congress of Clinical Toxicology, St. Louis, MI (September 1997)

Wallace KL, Suchard J, Curry SC, Reagan C: Accuracy and reliability of urine fluorescence by Wood's

lamp examination for antifreeze ingestion. North American Congress of Clinical Toxicology, La Jolla,

CA (October 1999)

Scholarly Poster Presentations

Wallace KL, Gerkin R, Mitchell R: Acute cyanide toxicity due to apricot kernel ingestion. North

American Congress of Clinical Toxicology, Portland,OR (October 1996)

Wallace KL, LoVecchio F, Kunkel DB, Carlton MW: Myokymia following snake envenomation in

Arizona. North American Congress of Clinical Toxicology, St. Louis, MI (September 1997)

Wallace KL, Curry SC, Graeme K: Effectiveness of flumazenil in the reversal of baclofen-induced CNS

depression in rats. North American Congress of Clinical Toxicology, St. Louis, MI (September 1997)

14

Kevin L. Wallace, MD, FACMT

Skolfield S, Lambert D, Tomassoni A, Wallace KL: Inadequate regional antidote and medication

supplies for poisoning emergencies. North American Congress of Clinical Toxicology, St. Louis, MI

(Sept. 1997)

Graeme KA, Wallace KL, Curry SC, Tanen DA, Higgins TJ: Hydrogen sulfide-induced changes in coin

appearance. North American Congress of Clinical Toxicology, Orlando, FL (September 1998)

LoVecchio F, Curry SC, Wallace KL, Graeme KA, Suchard JR: Pyridoxine \hydrochloride infusion

effect on acid-base status. North American Congress of Clinical Toxicology, Orlando, FL (September

1998)

Wallace KL, Curry SC, Brooks D: Post-collection rise in methemoglobin level in frozen blood. North

American Congress of Clinical Toxicology, Tucson, AZ (September 2000)

Wallace KL, Gerkin R, Gatewood P: Demonstration of clobenzorex exposure as an explanation for

GC/MS-confirmed positive urine tests specific for amphetamine. North American Congress of Clinical

Toxicology, Tucson, AZ (September 2000)

Brooks DE, Wallace KL, Katz K: Acute propylene glycol ingestion. North American Congress of

Clinical Toxicology, Montreal, Quebec (October 2001)

Ruha AM, Beuhler M, Brooks D, Wallace KL et al: CroFab for treatment of rattlesnake envenomation.

North American Congress of Clinical Toxicology, Montreal, Quebec (October 2001)

Brooks D, Wallace KL, Wax P, Watts D, Holubek W: Misleading liver needle biopsy in transplant

evaluation for acetaminophen-induced fulminant liver failure. North American Congress of Clinical

Toxicology, Palm Springs, CA (September 2002)

Health Effects of Indoor Mold Exposure. Payson Regional Medical Center, Payson, AZ (October 2002)

LoVecchio F, Klemens J, Curry SC, Wallace KL. Validation of a metformin poison center Protocol: a

48-month experience in toddlers. North American Congress of Clinical Toxicology, Chicago, IL

(September 2003)

Beuhler MC, Wallace KL. Benign outcome with toxic serum iron levels following IV iron Dextran

overdose in three patients. North American Congress of Clinical Toxicology, Chicago, IL (September

2003)

LoVecchio F, Watts D, Curry SC, Wallace KL. Acute renal failure, neuropathy, and Myopathy after

ingestion of dipropylene glycol-containing Fantasiaä fog solution. North American Congress of Clinical

Toxicology, Chicago, IL (September 2003)

Cannon R, Wallace K. Rapid clinical improvement after carnitine administration in valproate-induced

hyperammonemic encephalopathy (VHE). North American Congress of Clinical Toxicology, New

Orleans, LA (October 2007)

Riley BD, Quan D, Wallace KL. Early MRI findings do not appear predictive of outcome in severe

ethylene glycol-induced brain injury. North American Congress of Clinical Toxicology, New Orleans, LA

(October 2007)

15

Kevin L. Wallace, MD, FACMT

Gresham C,Wallace KL. Challenges in detection and confirmation of modafinil use. North American

Congress of Clinical Toxicology, Toronto, ON (September 2008)

Balk J, Holt C, Wallace K, Tu C, Lacroix M, McCall K. Controlled substance prescribing trends and

physician and pharmacy utilization patterns: epidemiological analysis of the Maine Prescription

Monitoring Program, 2006-2010. North American Primary Care Research Group Annual Meeting, Banff,

Alberta, Canada (November 2011)

Recorded Audiovideo Presentations

Wallace KL. Introduction to Toxic Risk Assessment. New England Consortium of Poison Control

Centers: Addressing Concerns Regarding Low-Intensity Environmental Exposures. (March 2004).

Wallace KL. Principles of Risk Assessment. New England Consortium of Poison Control Centers:

Addressing Concerns Regarding Low-Intensity Environmental Exposures. (June 2004).

Grant Support

1995 Orphan Medical Corporation (corporate multicenter trial sponsor)

1996 Palms Hospital Clinic Foundation (private foundation)

1998 Palms Hospital Clinic Foundation (private foundation)

2003-2004 Poison Control Ctr. Stabilization & Enhancement Grant (HRSA CFDA #93.253)

2005-2006 Environmental Health Sciences Center at Dartmouth (institutional pilot grant)

ACMT/ATSDR – Chemical Agents of Opportunity

2006 (cooperative educational grant)

Virginia Department of Health – Lead Prevention

2008 (cooperative educational grant)

16



Contact this candidate